AMENTUM HOLDINGS INC (AMTM)

US0239391016 - Common Stock

21.51  -2.27 (-9.55%)

After market: 21.3 -0.21 (-0.98%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMTM. AMTM was compared to 80 industry peers in the Professional Services industry. AMTM has a bad profitability rating. Also its financial health evaluation is rather negative. AMTM is not valued too expensively and it also shows a decent growth rate.



0

1. Profitability

1.1 Basic Checks

AMTM had negative earnings in the past year.

1.2 Ratios

AMTM's Return On Assets of -5.17% is on the low side compared to the rest of the industry. AMTM is outperformed by 77.92% of its industry peers.
With a Return On Equity value of -118.77%, AMTM is not doing good in the industry: 88.31% of the companies in the same industry are doing better.
With a Return On Invested Capital value of 3.14%, AMTM perfoms like the industry average, outperforming 41.56% of the companies in the same industry.
Industry RankSector Rank
ROA -5.17%
ROE -118.77%
ROIC 3.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of AMTM (2.38%) is worse than 63.64% of its industry peers.
Looking at the Gross Margin, with a value of 10.44%, AMTM is doing worse than 92.21% of the companies in the same industry.
Industry RankSector Rank
OM 2.38%
PM (TTM) N/A
GM 10.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

2.2 Solvency

AMTM has a Debt/Equity ratio of 14.78. This is a high value indicating a heavy dependency on external financing.
AMTM has a Debt to Equity ratio of 14.78. This is amonst the worse of the industry: AMTM underperforms 94.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 14.78
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.36
WACC8.8%

2.3 Liquidity

AMTM has a Current Ratio of 1.34. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
AMTM has a Current ratio (1.34) which is in line with its industry peers.
AMTM has a Quick Ratio of 1.34. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.34, AMTM perfoms like the industry average, outperforming 50.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34

4

3. Growth

3.1 Past

The earnings per share for AMTM have decreased strongly by -271.58% in the last year.
AMTM shows a small growth in Revenue. In the last year, the Revenue has grown by 2.46%.
EPS 1Y (TTM)-271.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AMTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.78% yearly.
AMTM is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.73% yearly.
EPS Next Y125.92%
EPS Next 2Y64.4%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue Next Year77.89%
Revenue Next 2Y34.64%
Revenue Next 3Y23.73%
Revenue Next 5YN/A

3.3 Evolution

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMTM. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 14.96, which indicates a correct valuation of AMTM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMTM indicates a somewhat cheap valuation: AMTM is cheaper than 72.73% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.38. AMTM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.96

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.4

4.3 Compensation for Growth

AMTM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 41.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.4%
EPS Next 3Y41.78%

0

5. Dividend

5.1 Amount

No dividends for AMTM!.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (12/17/2024, 8:41:01 PM)

After market: 21.3 -0.21 (-0.98%)

21.51

-2.27 (-9.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.23B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.96
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.17%
ROE -118.77%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.38%
PM (TTM) N/A
GM 10.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 14.78
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-271.58%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y125.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2.46%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y